通过Ubiquitin-Proteasome通路通过EZH2-Targeted PROTACs对PRC2复合物的化学诱导降解
Mingwei Fu1, Yuanjiang Wang2, Min Ge3
1Pharmaceutical Research Center and School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, PR China; Zenji Research Laboratories, Nanjing 211189, PR China.
Bioorganic & medicinal chemistry letters
|September 18, 2024
概括
开发了新的PROTAC化合物,其向的目标是增强肠胃同源2 (EZH2). 化合物ZJ-20有效降解了癌细胞中的PRC2复合物,显示为改善癌症治疗的前沿.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 增强体质同源2 (EZH2) 是癌症生物学中的一个关键的基因素甲基转移酶.
- 目前的EZH2抑制剂具有有限的临床疗效.
研究的目的:
- 设计和合成新型EZH2向的蛋白质溶解向嵌合体 (PROTACs).
- 改善现有的EZH2抑制剂的局限性.
主要方法:
- 在设计PROTAC化合物时,使用Tazemetostat作为感兴趣的蛋白质 (POI) 连接体.
- 在PROTAC设计中使用了各种连接器.
- 在实验室中评估了疗效和药理动力学特性.
主要成果:
- 化合物ZJ-20表现出强烈的活性,IC50为5.0nM,对MINO细胞具有强烈的活性.
- ZJ-20表现出有利的药理动力学参数.
- 通过准EZH2.2,ZJ-20成功诱导了PRC2复合物的降解.
结论:
- ZJ-20代表了开发下一代EZH2向癌症治疗的有希望的化合物.
- PROTAC技术提供了一种可行的策略,以克服EZH2抑制剂的局限性.
相关概念视频
Regulated Protein Degradation
7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
The Proteasome
818
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
818
Export of Misfolded Proteins out of the ER
3.5K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.5K
The Unfolded Protein Response
4.5K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.5K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
The Proteasome Structure
716
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
716


